Business
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the launch of the first tranche of its new share buyback program with a total volume of around EUR 1 billion. The first tranche, amounting up to EUR 600 million, was initiated today and is expected to be completed by December 15, 2026.
About this update from Fresenius Medical Care Ag
[{"type":"text","content":"BAD HOMBURG, Germany, May 28, 2026 /PRNewswire/ -- Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the launch of the first tranche of its new share buyback program with a total volume of around EUR 1 billion. The first tranche, amounting up to EUR 600 million, was initiated today and is expected to be completed by December 15, 2026.","length":427,"tagName":"p"},{"type":"image","alt":"Fresenius Medical Care (PRNewsfoto/Fresenius Medical Care North Am)","displaySize":"","headline":null,"caption":"Fresenius Medical Care (PRNewsfoto/Fresenius Medical Care North Am)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":86,"url":"https://media.zenfs.com/en/prnewswire.com/1ea334d2fed6b92c9bd382003cb7c081"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/95PSlUs75fNUr6f2LFPm6A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1Mg--/https://media.zenfs.com/en/prnewswire.com/1ea334d2fed6b92c9bd382003cb7c081","width":400,"height":86},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/8j6yRzc0UTE_nyFjC5E6Ug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTEzOA--/https://media.zenfs.com/en/prnewswire.com/1ea334d2fed6b92c9bd382003cb7c081","width":400,"height":86}},"href":"https://mma.prnewswire.com/media/655917/FMC_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The share buyback program is part of the Company's capital allocation framework, complementing dividends and reflecting FME's commitment to disciplined, value-focused capital management.","length":194,"tagName":"p"},{"type":"text","content":"The program is based on the authorization to purchase and use treasury shares granted by the Company's Annual General Meeting on May 21, 2026.","length":146,"tagName":"p"},{"type":"text","content":"FME will provide regular updates on the progress of the share buyback program at: Share buyback | Fresenius Medical Care","length":120,"tagName":"p"},{"type":"text","content":"About Fresenius Medical Care:Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 4.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,539 dialysis clinics, Fresenius Medical Care provides dialysis treatments for appr...